Aptamer Group Ltd appoints Jordan Clark as Chief Commercial Officer

Aptamer Group, the developer of Optimer biotherapeutics and diagnostics, is pleased to announce the appointment of Jordan Clark as Chief Commercial Officer at Aptamer Group with immediate effect.